Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With Dercum's Disease Lipomas [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating CBL-514 for safety and efficacy in Dercum's disease lipomas has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dercum Disease

Drugs mentioned

• CBL-514

Snippet

Sponsor: Caliway Biopharmaceuticals Co., Ltd. | Conditions: Dercum's Disease | Phase 2 | Status: COMPLETED